Recommended Therapies for Polycythemia Vera Underused
Phlebotomy and hydroxyurea tied to improved survival, lower risk for thrombosis in older patients.
Diagnosis & Disease Information
A Retrospective Look at Drug Sensitivity Before and After Checkpoint Blockade in R/R NHL
Checkpoint-based therapies may sensitize patients to subsequent therapies.
FDA Grants Approval to New Treatment for Acute Myeloid Leukemia
Randomized clinical trial showed significant improvement in overall survival with glasdegib.
Curative Option Identified for Squamous Cell Carcinoma of the Anal Canal With Distant Metastasis
A retrospective review identified a subset of patients with squamous cell carcinoma of the anal canal with distant metastases who respond to extended-field chemoradiation.
Perspectives on Use of Sensored Medication Devices From Patients With Multiple Myeloma
Researchers conducted a study to gauge the potential acceptance of sensored medication devices among patients with multiple myeloma.
Lung Cancer-Specific Distress Screening Tool Not Needed But Has Potential Benefit
Using focus groups, researchers evaluated patient-reported psychosocial consequences of lung cancer to determine if a lung cancer-specific distress screening instrument would benefit these patients.
Immunotherapy Side Effects May Be More Common Than Thought
Higher rates of adverse events observed for immune checkpoint inhibitors in real-world settings, compared to clinical trials.
Obesity as a Teen Ups Risk for Later Pancreatic Cancer
In men, overweight and even higher normal weight is associated with an increased risk of future pancreatic cancer.
Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
Researchers reviewed cancer incidence in patients with Diamond-Blackfan anemia.
G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
A meta-analysis of 14 randomized, controlled trials was conducted to determine if combining G-CSF with intensified chemotherapy improved overall survival.
- Loading...
Loading...
Next post in Side-Effect Management
Loading... 
Loading...